These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36900213)
1. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213 [TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy. Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747 [TBL] [Abstract][Full Text] [Related]
3. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma. Hu D; Zhang Z; Zhang Y; Huang K; Li X Front Genet; 2023; 14():1137995. PubMed ID: 37007965 [No Abstract] [Full Text] [Related]
4. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer. Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071 [TBL] [Abstract][Full Text] [Related]
5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration. Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559 [No Abstract] [Full Text] [Related]
7. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification. Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026 [TBL] [Abstract][Full Text] [Related]
8. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer. Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026 [TBL] [Abstract][Full Text] [Related]
10. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
11. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
12. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer. Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503 [No Abstract] [Full Text] [Related]
13. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma. Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678 [TBL] [Abstract][Full Text] [Related]
14. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998 [TBL] [Abstract][Full Text] [Related]
15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164 [No Abstract] [Full Text] [Related]
17. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis. Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732 [TBL] [Abstract][Full Text] [Related]
18. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Chen D; Guo W; Yu H; Yang J Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271 [TBL] [Abstract][Full Text] [Related]
20. Elucidating prognosis in cervical squamous cell carcinoma and endocervical adenocarcinoma: a novel anoikis-related gene signature model. Wang M; Ying Q; Ding R; Xing Y; Wang J; Pan Y; Pan B; Xiang G; Liu Z Front Oncol; 2024; 14():1352638. PubMed ID: 38988712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]